Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Patients' characteristics influencing the longitudinal Utilization of Steroids in Multiple Sclerosis - an observational study.

Rommer PS, Buckow K, Ellenberger D, Friede T, Pitschnau-Michel D, Fuge J, Stüve O, Zettl UK; German Multiple Sclerosis (MS) Registry of the German National MS Society(DMSG).

Eur J Clin Invest. 2015 Apr 13. doi: 10.1111/eci.12450. [Epub ahead of print]

PMID:
25868705
2.

Regression to the mean and predictors of MRI disease activity in RRMS placebo cohorts--is there a place for baseline-to-treatment studies in MS?

Stellmann JP, Stürner KH, Young KL, Siemonsen S, Friede T, Heesen C.

PLoS One. 2015 Feb 6;10(2):e0116559. doi: 10.1371/journal.pone.0116559. eCollection 2015.

3.

Guest editors' introduction. Preface.

Friede T, Henderson R, Hougaard P.

Stat Med. 2014 Dec 30;33(30):5221-2. doi: 10.1002/sim.6362. No abstract available.

PMID:
25487915
4.

Spline-based procedures for dose-finding studies with active control.

Helms HJ, Benda N, Zinserling J, Kneib T, Friede T.

Stat Med. 2015 Jan 30;34(2):232-48. doi: 10.1002/sim.6320. Epub 2014 Oct 16.

5.

Interleukin-2 receptor antagonists for pediatric liver transplant recipients: a systematic review and meta-analysis of controlled studies.

Crins ND, Röver C, Goralczyk AD, Friede T.

Pediatr Transplant. 2014 Dec;18(8):839-50. doi: 10.1111/petr.12362. Epub 2014 Oct 4.

PMID:
25283839
6.

Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice.

Vormfelde SV, Abu Abed M, Hua TD, Schneider S, Friede T, Chenot JF.

Dtsch Arztebl Int. 2014 Sep 12;111(37):607-14. doi: 10.3238/arztebl.2014.0607.

7.

Primum non nocere: shared informed decision making in low back pain--a pilot cluster randomised trial.

Patel S, Ngunjiri A, Hee SW, Yang Y, Brown S, Friede T, Griffiths F, Lord J, Sandhu H, Thistlethwaite J, Tysall C, Underwood M.

BMC Musculoskelet Disord. 2014 Aug 21;15:282. doi: 10.1186/1471-2474-15-282.

8.

Cerebrospinal fluid apolipoprotein E concentration and progression of Alzheimer's disease.

Schmidt C, Gerlach N, Peter C, Gherib K, Lange K, Friede T, Zerr I.

J Alzheimers Dis. 2015;43(4):1229-36. doi: 10.3233/JAD-141581.

PMID:
25125466
9.

Work-related outcomes in randomised placebo-controlled pain trials: a systematic review and meta-analysis.

Wolf I, Friede T, Hallier E, Straube S.

J Occup Med Toxicol. 2014 Jul 15;9:25. doi: 10.1186/1745-6673-9-25. eCollection 2014.

10.

CR1 is potentially associated with rate of decline in sporadic Alzheimer's disease.

Schmidt C, Wolff M, von Ahsen N, Lange K, Friede T, Zerr I.

J Clin Neurosci. 2014 Oct;21(10):1705-8. doi: 10.1016/j.jocn.2014.03.015. Epub 2014 Jul 4.

PMID:
24998857
11.

Point and interval estimators of the target dose in clinical dose-finding studies with active control.

Helms HJ, Benda N, Friede T.

J Biopharm Stat. 2014 Jun 11. [Epub ahead of print]

PMID:
24918730
12.

Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care.

Chenot JF, Hua TD, Abu Abed M, Schneider-Rudt H, Friede T, Schneider S, Vormfelde SV.

BMC Fam Pract. 2014 May 25;15:104. doi: 10.1186/1471-2296-15-104.

13.

Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data.

Kunz CU, Friede T, Parsons N, Todd S, Stallard N.

Pharm Stat. 2014 Jul-Aug;13(4):238-46. doi: 10.1002/pst.1619. Epub 2014 May 2.

14.

Multiple sclerosis registries in Europe - results of a systematic survey.

Flachenecker P, Buckow K, Pugliatti M, Kes VB, Battaglia MA, Boyko A, Confavreux C, Ellenberger D, Eskic D, Ford D, Friede T, Fuge J, Glaser A, Hillert J, Holloway E, Ioannidou E, Kappos L, Kasilingam E, Koch-Henriksen N, Kuhle J, Lepore V, Middleton R, Myhr KM, Orologas A, Otero S, Pitschnau-Michel D, Rienhoff O, Sastre-Garriga J, Schyns-Liharska T, Sutovic D, Thalheim C, Trojano M, Vlasov YV, Yaldizli O; EUReMS Consortium.

Mult Scler. 2014 Oct;20(11):1523-32. doi: 10.1177/1352458514528760. Epub 2014 Apr 28.

PMID:
24777278
15.

Blinded sample size re-estimation in crossover bioequivalence trials.

Golkowski D, Friede T, Kieser M.

Pharm Stat. 2014 May-Jun;13(3):157-62. doi: 10.1002/pst.1617. Epub 2014 Apr 9.

PMID:
24715672
16.

A comparison of methods for treatment selection in seamless phase II/III clinical trials incorporating information on short-term endpoints.

Kunz CU, Friede T, Parsons N, Todd S, Stallard N.

J Biopharm Stat. 2015;25(1):170-89. doi: 10.1080/10543406.2013.840646.

17.

Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis.

Chenot JF, Weber P, Friede T.

BMC Fam Pract. 2014 Mar 13;15:45. doi: 10.1186/1471-2296-15-45.

18.

Plasma prion protein concentration and progression of Alzheimer disease.

Schmidt C, Becker H, Peter C, Lange K, Friede T, Zerr I.

Prion. 2014 Mar-Apr;8(2). pii: 27964. Epub 2014 Feb 18.

PMID:
24549099
19.

Sources of information and behavioral patterns in online health forums: observational study.

Sudau F, Friede T, Grabowski J, Koschack J, Makedonski P, Himmel W.

J Med Internet Res. 2014 Jan 14;16(1):e10. doi: 10.2196/jmir.2875.

20.

Adaptive designs for confirmatory clinical trials with subgroup selection.

Stallard N, Hamborg T, Parsons N, Friede T.

J Biopharm Stat. 2014;24(1):168-87. doi: 10.1080/10543406.2013.857238. Review.

PMID:
24392984
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk